NCT05474664View on ClinicalTrials.gov

Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

July 12, 2024

Study Completion Date

October 8, 2024

Conditions
Fontan OperationProtein-Losing EnteropathyCamostat Mesylate
Interventions
DRUG

Camostat mesylate

"1. 4\~12 years old: Camostate mesylate 100 mg, 2 times a day~2. greater than 13 years old: Camostate mesylate 100 mg, 3 times a day"

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER